Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh

Journal of Medical Virology

Volumn 82, Issue 8, 2010, Pages 1350-1354

  Al Mahtab, Mamun ^a   Rahman, Salimur ^a   Akbar, Sheikh Mohammad Fazle ^b   Kamal, Mohammad ^a   Khan, Mohammad Sakirul Islam ^c  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b Shinagawa ku   (Japan)

^c BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

Author keywords

HBV carrier; Hepatic necroinflammation; Inactive; Liver biopsy; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; BANGLADESH; CLINICAL ARTICLE; DISEASE SEVERITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; MALE; VIRUS CARRIER; BIOPSY; BLOOD; CYTOCHEMISTRY; FEMALE; HETEROZYGOTE; ISOLATION AND PURIFICATION; LIVER; LIVER CIRRHOSIS; MICROSCOPY; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; BANGLADESH; BIOPSY; CARRIER STATE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HISTOCYTOCHEMISTRY; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICROSCOPY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

HEPATITIS B VIRUS;

EID: 77956574956     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21830     Document Type: Article

References (21)

1. Akbar SM, Hiasa Y, Mishiro S, Onji M. 2009. Treatment of hepatitis B virus-infected patients: Utility of therapeutic recommendations in developing countries. Expert Opin Pharmacother 10:1605-1614.
2. Bertoletti A, Maini M, Williams R. 2003. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res 60:61-66.
3. Chu CM, Liaw YF. 2009. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 104:1693-1699.
4. El-Zayadi AR, Badran HM, Saied A, Shawky S, El-Deen Attia M, Zalata K. 2009. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: Implications for therapy. Am J Gastroenterol 104:906-911.
5. European Association for the Study of the Liver. 2009. EASL clinical practice guidelines; management of chronic hepatitis B. J Hepatol 50:227-242.
6. Fattovich G, Bortolotti F, Donato F. 2008. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. J Hepatol 48:335-352.
7. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ. 2007. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 46:1057-1070.
8. Ganem D, Prince AM. 2004. Hepatitis B virus infection - Natural history and clinical consequences. N Engl J Med 350:1118-1129.
9. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. 2008. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6:1315-1341.
10. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
11. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S. 2008. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134:1376-1384.
12. Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK. 2009. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients. Gastroenterology 136:1272-1280.
13. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. 2007. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 47:760-767. (Pubitemid 350051121)
14. Liaw YF. 2009. Hepatitis B virus infection. Lancet 373:582-592.
15. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S, For the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver. 2008. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol Int 22:262-283.
16. Lok AS, McMahon BJ. 2009. AASLD guidelines chronic hepatitis b; update 2009. Hepatology 50:1-36.
17. Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ. 2008. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology 48:1451-1459.
18. Perz JF, Armstrong GL, Farrington LA, Huttin YJF, Bell BP. 2006. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529-538.
19. Shiha G, Sarin SK, Ibrahim AE, Omata M, Kumar A, Lesmana LA, Leung N, Tozun N, Hamid S, Jafri W, Maruyama H, Bedossa P, Pinzani M, Chawla Y, Esmat G, Doss W, Elzanaty T, Sakhuja P, Nasr AM, Omar A, Wai CT, Abdallah A, Salama M, Hamed A, Yousry A, Waked I, Elsahar M, Fateen A, Mogawer S, Hamdy H, Elwakil R, Jury of the APASL Consensus Development Meeting 29 January 2008 on Liver Fibrosis With or Without Hepatitis B or C. 2009. Liver fibrosis: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 3:323-333.
20. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. 2009. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 49:1859-1867.
21. Wai CT, Mak B, Chua W, Lin CG. 2004. The majority of hepatitis B virus carriers are not on regular surveillance in Singapore. Singapore Med J 45:423-426.